Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Therapy for type 2 diabetes mellitus

D F Elson1, M Meredith

  • 1University of Wisconsin Hospitals and Clinics, Madison, USA.

WMJ : Official Publication of the State Medical Society of Wisconsin
|April 16, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Shelf-ocean exchange and hydrography west of the Antarctic Peninsula: a review.

Philosophical transactions. Series A, Mathematical, physical, and engineering sciences·2018
Same author

Chemosensory cues affect amygdaloid neurogenesis and alter behaviors in the socially monogamous prairie vole.

The European journal of neuroscience·2014
Same author

Change in number and activation of androgen receptor-immunoreactive cells in the medial amygdala in response to chemosensory input.

Neuroscience·2011
Same author

Oxytocin antagonist disrupts male mouse medial amygdala response to chemical-communication signals.

Neuroscience·2011
Same author

The vomeronasal organ is required for the male mouse medial amygdala response to chemical-communication signals, as assessed by immediate early gene expression.

Neuroscience·2009
Same author

The tensor distribution function.

Magnetic resonance in medicine·2008
Same journal

Erratum.

WMJ : official publication of the State Medical Society of Wisconsin·2026
Same journal

Proceedings From the 2025 Medical College of Wisconsin Innovations in Healthcare Education Research Annual Conference.

WMJ : official publication of the State Medical Society of Wisconsin·2026
Same journal

Starvation Ketosis Versus Euglycemic Diabetic Ketoacidosis in Pregnancy: A Case Report Highlighting the Diagnostic Overlap.

WMJ : official publication of the State Medical Society of Wisconsin·2026
Same journal

Should We Consider the Use of Buprenorphine for Pain Management in Nonsurgical Candidates With End-stage Osteoarthritis? A Case Report.

WMJ : official publication of the State Medical Society of Wisconsin·2026
Same journal

Phlegmasia Cerulea Dolens With Compartment Syndrome.

WMJ : official publication of the State Medical Society of Wisconsin·2026
Same journal

A Case of Low-Dose Ceftriaxone-Induced Liver Injury in an Adult.

WMJ : official publication of the State Medical Society of Wisconsin·2026
See all related articles

Type 2 diabetes affects 6% of US adults, increasing morbidity and mortality. Controlling blood glucose with oral medications or insulin significantly reduces complications, improving patient outcomes.

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Pharmacology

Background:

  • Type 2 diabetes mellitus (T2DM) is a prevalent chronic disease impacting nearly 6% of the US adult population.
  • It is a significant contributor to morbidity and mortality, both nationally and in regions like Wisconsin.
  • Evidence strongly links glycemic control in T2DM patients to reduced development and progression of microvascular and macrovascular complications.

Purpose of the Study:

  • To compare and contrast available oral medication classes for T2DM treatment.
  • To discuss the appropriate use of these agents in monotherapy and combination therapy.
  • To outline the role of insulin in patients with T2DM who have not responded to oral therapies.

Main Methods:

  • Review of four classes of oral diabetes medications: sulfonylureas, biguanides, thiazolidinediones, and alpha-glucosidase inhibitors.

Related Experiment Videos

  • Analysis of the distinct mechanisms of action for each drug class targeting impaired insulin secretion, insulin resistance, and postprandial hyperglycemia.
  • Discussion of therapeutic strategies, including monotherapy, combination therapy, and insulin use.

    • Main Results:

    • Oral diabetes medications work through diverse mechanisms to address underlying T2DM pathophysiology.
    • Tailored therapeutic approaches, considering individual metabolic abnormalities, are crucial for effective glycemic control.
    • Newer treatment options offer expanded possibilities for managing T2DM and potentially preventing the disease in at-risk individuals.

    Conclusions:

    • Rational and individualized use of available pharmacologic tools can achieve good glycemic control in most T2DM patients.
    • Understanding the underlying defects of T2DM, including insulin resistance and impaired insulin secretion, guides treatment selection.
    • Despite increasing prevalence, advancements in T2DM treatment offer improved management and potential for prevention.